Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 7795459.
- Also identified by PMC identifier 2550020.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Postmarketing research, often called phase IV trials, is intended to familiarise doctors and patients with newly approved drugs. La Puma and colleagues, in Chicago, studied doctors' and patients' attitudes to whether doctors should receive payment for taking part in such research. We asked for commentaries on their findings from four ethical experts, who put the study in a British context, present the views of patients, and examine some methodological assumptions.
Medical subject headings
- Attitude to Health
- Conflict of Interest
- Disclosure
- Fees, Medical
- Informed Consent
- Product Surveillance, Postmarketing
- Therapeutic Human Experimentation